Pharmaceutical News

RSS

Researchers develop antibody drugs from tobacco plants for cancer treatment

For the first time in Thailand, lecturers at Chulalongkorn University's Faculty of Pharmaceutical Sciences have successfully developed antibody from tobacco plants with inhibitory effects on the growth of cancer cells in laboratory animals.

9 Aug 2023

The immune-modulatory effect of lenvatinib investigated in new study

Researchers explore the effect of lenvatinib treatment on patients with advanced thyroid cancer.

9 Aug 2023

New guidance provides clear advice to reduce medication errors in anesthesia care

New guidance published in Anaesthesia (the journal of the Association of Anaesthetists) provides clear advice to reduce avoidable errors on all steps of the pathway involving injectable medications used routinely in anesthesia care.

8 Aug 2023

Seeking Medicare coverage for weight loss drugs, pharma giant courts Black influencers

Pharmaceutical giant Novo Nordisk has turned to influential Black Americans in pursuit of what would be a lucrative victory: having Medicare cover a new class of weight loss drugs, including the company's highly sought Wegovy, which can cost patients more than $1,000 a month.

8 Aug 2023

University of Michigan and Zingerman's launch pilot program to train employees in use of naloxone

In an effort to expand the use of lifesaving opioid overdose reversal medication, the University of Michigan and Ann Arbor’s Zingerman’s Community of Businesses are launching a restaurant-based pilot program in Michigan to train employees in the use and administration of naloxone.

7 Aug 2023

Exploring the safety of COVID-19 mRNA vaccines in the elderly

Researchers evaluate the risks of possible adverse events following COVID-19 mRNA vaccination in the elderly.

7 Aug 2023

Survey: Americans want weight loss drugs despite high cost

Many Americans really want to lose weight — and a new poll shows nearly half of adults would be interested in taking a prescription drug to help them do so.

5 Aug 2023

Penn State researchers develop new method for creating cyclopropanes

Chemical structures called cyclopropanes can increase the potency and fine-tune the properties of many drugs, but traditional methods to create this structure only work with certain molecules and require highly reactive - potentially explosive - ingredients. Now, a team of researchers from Penn State has identified and demonstrated a safe, efficient and practical way to create cyclopropanes on a wide variety of molecules using a previously undescribed chemical process.

4 Aug 2023

New study provides promising results for metformin in periodontitis

Periodontitis, a prevalent global health concern, results in the gradual destruction of tooth-supporting tissues and is often exacerbated by oxidative stress conditions and bacterial changes. Current treatment methodologies include mechanical debridement, anti-inflammatory drugs, and regenerative surgery.

4 Aug 2023

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

Researchers discuss the mechanisms of triptans for the treatment of spontaneous migraine attacks by using transcriptomics and metabolomics.

3 Aug 2023

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

In a recent study, researchers working at Ohio State University in the United States of America (USA) developed an intranasal subunit vaccine.

2 Aug 2023

Diligent Robotics' Moxi robot revolutionizes medication delivery at CHLA

Whether it's R2-D2, Wall-E, Rosie from "The Jetsons," or your own personal Roomba, chances are you've been captivated by at least one robot in your lifetime. It seems most kids (and kids at heart) find robots equal parts mystifying, useful and endearing.

1 Aug 2023

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers investigated the safety and pharmacokinetics of JNJ-54175446 in a double-blind, multicenter, randomized controlled trial (RCT).

31 Jul 2023

Researchers discover new spiroindolin-1,2-diazepine derivatives with anti-Alzheimer therapeutic potential

In a recent study, researchers designed substituted spiro indolin-1,2-diazepine derivatives '5a–v' with cholinesterase inhibitory activities as anti-Alzheimer's disease agents.

31 Jul 2023

Increasing COVID-19 booster vaccine uptake: The impact of one-time personal reminder messages

The rate of COVID-19 booster vaccination can be increased considerably by sending one-time personal reminders.

27 Jul 2023

New collaboration to investigate forms of RNA modification

Universität Mainz Institute of Pharmaceutical and Biomedical Sciences of Mainz University to collaborate with Monash University and ETH Zurich to investigate forms of RNA modification.

27 Jul 2023

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

The University of Texas MD Anderson Cancer Center and Nexo Therapeutics today announced a multi-year strategic collaboration that aligns the innovative technology and capabilities of each organization at the earliest stages of drug discovery and development to rapidly advance impactful new cancer therapies against previously undruggable targets.

26 Jul 2023

Tumor-derived GDF-15 suppresses immunotherapy response

Researchers evaluate the impact of tumor-derived GDF-15 on responses to anti-PD-1 immunotherapy.

26 Jul 2023

Drug interferon proven effective to reduce the spread of COVID-19

Results of an innovative clinical trial led by Perth researchers have shown that the drug interferon could help reduce the spread of COVID-19 from a positive person to their household contacts, with the study helping to inform treatment options for a future pandemic.

26 Jul 2023

Study identifies barriers to prescribing medications for alcohol use disorder in primary care

Researchers explored how primary care physicians who have some familiarity with medications for alcohol use disorder (MAUD) make prescribing decisions and identify reasons for the underuse of MAUD in primary care.

25 Jul 2023

Previous
1
...
53
54
55
56
57
58
59
...
1443
Next

Pharmaceutical News

Researchers develop antibody drugs from tobacco plants for cancer treatment

The immune-modulatory effect of lenvatinib investigated in new study

New guidance provides clear advice to reduce medication errors in anesthesia care

Seeking Medicare coverage for weight loss drugs, pharma giant courts Black influencers

University of Michigan and Zingerman's launch pilot program to train employees in use of naloxone

Exploring the safety of COVID-19 mRNA vaccines in the elderly

Survey: Americans want weight loss drugs despite high cost

Penn State researchers develop new method for creating cyclopropanes

New study provides promising results for metformin in periodontitis

The mechanisms of triptan using metabolomics and transcriptomics in spontaneous migraine attacks

Intranasally administered SARS-CoV-2 RBD-based nanoparticle vaccine provides protection against lung pathology and viral load

Diligent Robotics' Moxi robot revolutionizes medication delivery at CHLA

Trial evaluates purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder

Researchers discover new spiroindolin-1,2-diazepine derivatives with anti-Alzheimer therapeutic potential

Increasing COVID-19 booster vaccine uptake: The impact of one-time personal reminder messages

New collaboration to investigate forms of RNA modification

MD Anderson and Nexo Therapeutics partner to advance new cancer therapies against previously undruggable targets

Tumor-derived GDF-15 suppresses immunotherapy response

Drug interferon proven effective to reduce the spread of COVID-19

Study identifies barriers to prescribing medications for alcohol use disorder in primary care

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News